DIABETES Rapamycin/IL-2 Combination Therapy in Patients with Type 1 Diabetes Augments Tregs yet Transiently Impairs β-Cell Function Rapamycin/interleukin-2 (IL-2) therapy resulted in transient β-cell dysfunction despite an increase in regulatory T cells (Tregs). [Diabetes] Abstract Administration of CD4+CD25highCD127− Regulatory T Cells Preserves β-Cell Function in Type 1 Diabetes in Children Researchers show for the first time that the infusion of autologous regulatory T cells prolongs remission in recently diagnosed type 1 diabetes in children. [Diabetes Care] Abstract Abnormal Glucose Tolerance and Insulin Secretion in Pancreas-Specific Tcf7l2-null Mice Investigators sought to determine whether selective deletion of the T cell factor 7 like-2 gene (Tcf7l2) in mouse pancreas impairs insulin release and glucose homeostasis. Glucose tolerance, insulin secretion from isolated islets, and plasma insulin, glucagon and glucagon-like peptide 1 content were assessed by standard protocols. [Diabetologia] Abstract Spinophilin as a Novel Regulator of M3 Muscarinic Receptor-Mediated Insulin Release In Vitro and In Vivo Researchers examined the ability of spinophilin (SPL) to modulate the activity of β-cell M3 muscarinic acetylcholine receptors (M3Rs). They demonstrated, by using both in vitro and in vivo approaches, that SPL is a potent negative regulator of M3R-mediated signaling and insulin release. [FASEB J] Abstract The Ontogeny of the Endocrine Pancreas in the Fetal/Newborn Baboon The authors examined histological and ultra-structural differences in the endocrine pancreas in fetal (throughout gestation) and neonatal baboons. [J Endocrinol] Abstract PANCREATIC CANCER sox9b Is a Key Regulator of Pancreaticobiliary Ductal System Development The data reveal key roles for SOX9 in the morphogenesis of the pancreaticobiliary ductal system, and they cast human Sox9 as a candidate gene for pancreaticobiliary duct malformation-related pathologies. [PLoS Genet] Full Article Oxidative Inhibition of Hsp90 Disrupts the Super-Chaperone Complex and Attenuates Pancreatic Adenocarcinoma In Vitro and In Vivo Researchers investigated the oxidative stress-mediated dysfunction of Hsp90 and the hindrance of its chaperonic activity by a carbazole alkaloid, mahanine, as a strategic therapeutic in pancreatic cancer. [Int J Cancer] Abstract YM155 Induces Epidermal Growth Factor Receptor Suppression in Pancreatic Cancer Cells Scientists tested the effects of YM155 on a variety of cancer cell lines, including pancreatic cancer cells. They found that YM155 exerts an anti-proliferative effect in pancreatic cancer cells, inducing cell death through suppression of X-linked inhibitor of apoptosis as well as survivin without affecting the anti-apoptotic proteins Bcl-xL or Mcl-1. [PLoS One] Full Article Analysis of Tumor-Induced Lymphangiogenesis and Lymphatic Vessel Invasion of Pancreatic Carcinoma in the Peripheral Nerve Plexus Researchers examined the role of lymphangiogenesis in the metastasis of pancreatic cancer to the peripheral nerve plexus. [Cancer Sci] Abstract Inhibition of Pancreatic Cancer Cell Growth In Vivo Using a Tetracycline-Inducible Cyclin D1 Antisense Expression System Investigators determined the effects of cyclin D1 inhibition on the growth of established pancreatic tumors. [Pancreas] Abstract |